mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.02 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
CAY10594 |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.02 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.02 |
mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.03 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.03 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.03 |
mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.03 |
mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.03 |